3,612
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Antibiofilm and quorum sensing inhibitory activity of Achyranthes aspera on cariogenic Streptococcus mutans: An in vitro and in silico study

, , , &
Pages 728-736 | Received 10 Nov 2012, Accepted 29 Dec 2012, Published online: 11 Apr 2013

Figures & data

Table 1. The growth and biofilm inhibitory activity of A. aspera extracts on cariogenic isolate S. mutans.

Figure 1. GC–MS chromatogram of anticariogenic methanol extract of A. aspera showing the compounds and their percentage of abundance (within parentheses). (1) 3-hydroxyoxolan-2-one (0.19); (2) oxane-2,6-dione (0.91); (3) 1,4-dimethylpiperazine (1.82); (4) methylglyoxal (0.98); (5) 4-hydroxy-2,5-dimethylfuran-3-one (1.39); (6) 4-methoxyphenol (0.32); (7) N-(3-methylbutyl)-N-pentylnitrous amide (0.35); (8) 3,3-diethyl-1-methyldiaziridine (0.28); (9) N-methyl-N-propan-2-ylnitrous amide (1.15); (10) 2,3,4,5-tetrahydroxypentanal (1.20); (11) 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one (9.80); (12) 4-hydroxyoxolan-2-one (0.48); (13) 3,5-dihydroxy-2-methylpyran-4-one (0.21); (14) benzene-1,2-diol (0.11); (15) 1-(furan-2-yl)ethane-1,2-diol (0.78); (16) 5-(hydroxymethyl)furan-2-carbaldehyde (60.33); (17) nonanoic acid (0.18); (18) 4-ethenyl-2-methoxyphenol (1.1); (19) hexyl 3-oxobutanoate (0.11); (20) 2,6-dimethoxyphenol (0.05); (21) 3-hydroxy-4-methoxybenzaldehyde (0.02); (22) (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl) oxolan-2-yl] oxy-6-(hydroxymethyl) oxane-3,4,5-triol (0.02); (23) 2-(hydroxymethyl)-2-nitropropane-1,3-diol (0.03); (24) 2-hydroxy-5-methylbenzene-1,3-dicarbaldehyde (0.01); (25) 1-methoxy-3,5-dimethylbenzene (0.12); (26) (1R,2S,3S,4R,5R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (0.12); (27) 1-(3,5-dimethoxyphenyl)ethanone (0.10); (28) oxan-4-ol (0.02); (29) 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione (0.11); (30) 1-(4-hydroxy-3,5-dimethoxyphenyl)ethanone (0.03); (31) 4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenol (0.05); (32) tetradecanoic acid (0.01); (33) 1-(2,6-dihydroxy-4-methoxyphenyl)butan-1-one (0.01); (34) 3-methyl-1-(4-phenylbenzoyl)-2-propan-2-ylimidazolidin-4-one (0.07); (35) 1-ethyl-2,3,4,5,6-pentamethylbenzene (0.03); (36) ethyl hexadecanoate (0.03); (37) (E)-3-(4-hydroxy-3,5-dimethoxyphenyl) prop-2-enal (0.01); (38) 2-hydroxy-4-methoxy-3,5,6-trimethylbenzoic acid (0.03); (39) henicosan-11-ylbenzene (0.04); (40) 2,7-diphenyl-1H-indole (0.09); (41) 2-[2-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]-6-phenylpyran-4-ylidene]propanedinitrile (0.10); (42) (3S,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (0.03); (43) 4,7-dimethoxy-1,1,4a-trimethyl-8-propan-2-yl-10,10a-dihydro-9H-phenanthren-2-one (0.12); (44) 1-chloroicosane (0.08); (45) 3-(4-chlorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazole-1,2-dicarboxylic acid (0.06); (46) (E)-3,5-bis(4-hydroxyphenyl)pent-4-ene-1,2-diol (0.04); (47) tetratetracontane (0.02); (48) 2,6-ditert-butyl-4-diazoniophenolate (0.04); (49) (2R,3R,11bS)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine (0.04); (50) 9-dodecyl-1,2,3,4,4a,5,6,7,8,8a,9,9a,10,10a-tetradecahydroanthracene (0.02); (51) 2-prop-1-en-2-ylpyrazine (0.05); (52) 7-amino-4-chloro-3-(cyclohexylmethoxy)isochromen-1-one (0.06); (53) (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol (0.05); (54) hexacosane (0.05); (55) 4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,4a,5,6,6a,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,13-dione (0.05); (56) (4,5-dimethyl-7a-prop-1-en-2-yl-2,3,3a,5,6,7-hexahydro-1H-inden-4-yl)methanol (0.04).

Figure 1. GC–MS chromatogram of anticariogenic methanol extract of A. aspera showing the compounds and their percentage of abundance (within parentheses). (1) 3-hydroxyoxolan-2-one (0.19); (2) oxane-2,6-dione (0.91); (3) 1,4-dimethylpiperazine (1.82); (4) methylglyoxal (0.98); (5) 4-hydroxy-2,5-dimethylfuran-3-one (1.39); (6) 4-methoxyphenol (0.32); (7) N-(3-methylbutyl)-N-pentylnitrous amide (0.35); (8) 3,3-diethyl-1-methyldiaziridine (0.28); (9) N-methyl-N-propan-2-ylnitrous amide (1.15); (10) 2,3,4,5-tetrahydroxypentanal (1.20); (11) 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one (9.80); (12) 4-hydroxyoxolan-2-one (0.48); (13) 3,5-dihydroxy-2-methylpyran-4-one (0.21); (14) benzene-1,2-diol (0.11); (15) 1-(furan-2-yl)ethane-1,2-diol (0.78); (16) 5-(hydroxymethyl)furan-2-carbaldehyde (60.33); (17) nonanoic acid (0.18); (18) 4-ethenyl-2-methoxyphenol (1.1); (19) hexyl 3-oxobutanoate (0.11); (20) 2,6-dimethoxyphenol (0.05); (21) 3-hydroxy-4-methoxybenzaldehyde (0.02); (22) (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl) oxolan-2-yl] oxy-6-(hydroxymethyl) oxane-3,4,5-triol (0.02); (23) 2-(hydroxymethyl)-2-nitropropane-1,3-diol (0.03); (24) 2-hydroxy-5-methylbenzene-1,3-dicarbaldehyde (0.01); (25) 1-methoxy-3,5-dimethylbenzene (0.12); (26) (1R,2S,3S,4R,5R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol (0.12); (27) 1-(3,5-dimethoxyphenyl)ethanone (0.10); (28) oxan-4-ol (0.02); (29) 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione (0.11); (30) 1-(4-hydroxy-3,5-dimethoxyphenyl)ethanone (0.03); (31) 4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenol (0.05); (32) tetradecanoic acid (0.01); (33) 1-(2,6-dihydroxy-4-methoxyphenyl)butan-1-one (0.01); (34) 3-methyl-1-(4-phenylbenzoyl)-2-propan-2-ylimidazolidin-4-one (0.07); (35) 1-ethyl-2,3,4,5,6-pentamethylbenzene (0.03); (36) ethyl hexadecanoate (0.03); (37) (E)-3-(4-hydroxy-3,5-dimethoxyphenyl) prop-2-enal (0.01); (38) 2-hydroxy-4-methoxy-3,5,6-trimethylbenzoic acid (0.03); (39) henicosan-11-ylbenzene (0.04); (40) 2,7-diphenyl-1H-indole (0.09); (41) 2-[2-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]-6-phenylpyran-4-ylidene]propanedinitrile (0.10); (42) (3S,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (0.03); (43) 4,7-dimethoxy-1,1,4a-trimethyl-8-propan-2-yl-10,10a-dihydro-9H-phenanthren-2-one (0.12); (44) 1-chloroicosane (0.08); (45) 3-(4-chlorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazole-1,2-dicarboxylic acid (0.06); (46) (E)-3,5-bis(4-hydroxyphenyl)pent-4-ene-1,2-diol (0.04); (47) tetratetracontane (0.02); (48) 2,6-ditert-butyl-4-diazoniophenolate (0.04); (49) (2R,3R,11bS)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine (0.04); (50) 9-dodecyl-1,2,3,4,4a,5,6,7,8,8a,9,9a,10,10a-tetradecahydroanthracene (0.02); (51) 2-prop-1-en-2-ylpyrazine (0.05); (52) 7-amino-4-chloro-3-(cyclohexylmethoxy)isochromen-1-one (0.06); (53) (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol (0.05); (54) hexacosane (0.05); (55) 4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,4a,5,6,6a,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,13-dione (0.05); (56) (4,5-dimethyl-7a-prop-1-en-2-yl-2,3,3a,5,6,7-hexahydro-1H-inden-4-yl)methanol (0.04).

Figure 2. Streptococcus mutans glucansucrase (PDB:3AIC) superimposed structure with A. aspera natural ligand phytochemicals Betulin (2a); (2R,3R,11bS)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7, 11b-hexahydro-1H-benzo[a]quinolizine (2b); 1,4-dimethylpiperazine (2c); 2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (2d); 2,3,4,5-tetrahydroxypentanal (2e); 3,5-dihydroxy-2-methylpyran-4-one (2f); 2-hydroxy-5-methylbenzene-1,3-dicarbaldehyde (2g) as well as 1-(4-hydroxy-3,5-dimethoxyphenyl)ethenone (2h). Molecular docking superimposed structures of Streptococcus OmpR subfamily response regulator (1NXO) with A. aspera phytochemical natural ligands (3S,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (3a); 3-(4-chlorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazole-1,2-dicarboxylic acid (3b); 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one (3c); 1-methoxy-3,5-dimethylbenzene (3d); 4,7-dimethoxy-1,1,4a-trimethyl-8-propan-2-yl-10,10a-dihydro-9H-phenanthren-2-one (3e); 5-(hydroxymethyl)furan-2-carbaldehyde (3f); 3-methyl-1-(4-phenylbenzoyl)-2-propan-2-ylimidazolidin-4-one (3g); and 4-hydroxy-2,5-dimethylfuran-3-one (3h).

Figure 2. Streptococcus mutans glucansucrase (PDB:3AIC) superimposed structure with A. aspera natural ligand phytochemicals Betulin (2a); (2R,3R,11bS)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7, 11b-hexahydro-1H-benzo[a]quinolizine (2b); 1,4-dimethylpiperazine (2c); 2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (2d); 2,3,4,5-tetrahydroxypentanal (2e); 3,5-dihydroxy-2-methylpyran-4-one (2f); 2-hydroxy-5-methylbenzene-1,3-dicarbaldehyde (2g) as well as 1-(4-hydroxy-3,5-dimethoxyphenyl)ethenone (2h). Molecular docking superimposed structures of Streptococcus OmpR subfamily response regulator (1NXO) with A. aspera phytochemical natural ligands (3S,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (3a); 3-(4-chlorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazole-1,2-dicarboxylic acid (3b); 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one (3c); 1-methoxy-3,5-dimethylbenzene (3d); 4,7-dimethoxy-1,1,4a-trimethyl-8-propan-2-yl-10,10a-dihydro-9H-phenanthren-2-one (3e); 5-(hydroxymethyl)furan-2-carbaldehyde (3f); 3-methyl-1-(4-phenylbenzoyl)-2-propan-2-ylimidazolidin-4-one (3g); and 4-hydroxy-2,5-dimethylfuran-3-one (3h).

Table 2. Achyranthes aspera phytochemical natural ligands as well as the antibiotic triclosan docking scores with the active site of S. mutans and S. aureus QS regulators and their predicted bioactivity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.